ARS Pharmaceuticals (SPRY) EPS (Diluted) (2021 - 2026)

ARS Pharmaceuticals (SPRY) EPS (Diluted) (2021 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EPS (Diluted) (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - 0.00
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 0.15
4 NuCana 279.75 Bn 279.75 Bn - -368,323.02
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 4.02
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 6.75
7 Belite Bio 62.51 Bn 62.51 Bn - 0.00
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn 7.33
9 Revolution Medicines 37.78 Bn 37.78 Bn - -2.29
10 ARS Pharmaceuticals 595.78 Mn 394.81 Mn - -0.97

Historic Data

Download Data
DateValue
Mar 31, 2026 -0.97
Dec 31, 2025 -0.44
Sep 30, 2025 -1.14
Jun 30, 2025 -2.26
Mar 31, 2025 -0.38
Dec 31, 2024 0.46
Sep 30, 2024 -1.60
Jun 30, 2024 -0.70
Mar 31, 2024 -0.94
Dec 31, 2023 -0.11
Sep 30, 2023 -161.76
Jun 30, 2023 -402.49
Mar 31, 2023 -418.21
Dec 31, 2022 -0.38
Sep 30, 2022 -0.43
Jun 30, 2022 -0.44
Mar 31, 2022 -0.38
Dec 31, 2021 1.63
Sep 30, 2021 -1.27